Hereditary Cancer Genetics, Explained
Most cancer is not inherited. But for the minority of families carrying a germline variant, a single change written into every cell can reshape lifetime risk — and understanding how that works is the first step toward acting on it. This is a mechanism-first guide, from the sample to the sequence.
Hereditary Cancer Genetics
Germline versus sporadic: where the change lives
Every cancer begins with DNA damage, but the location of the first change determines whether risk is inherited. A sporadic cancer arises from mutations acquired over a lifetime in a single tissue — driven by age, environment, and chance. Those changes are confined to the tumor; they are not passed to children. A germline variant is different: it is present in the egg or sperm at conception, so it is copied into every cell of the body, including the cells that form the next generation.
Because a germline variant is already in place from the start, a person who carries one needs fewer additional events for a cancer to develop. That is why hereditary syndromes tend to cause cancer earlier in life, sometimes in both paired organs, and often across several relatives. The variant itself does not guarantee cancer — it shifts probability. Quantifying that shift, and acting on it through screening or risk reduction, is the practical purpose of genetic testing.
What this hub covers
Five connected topics, each building on the last — from how a sample becomes a sequence, to what the result means for a patient and their family.
Multi-Gene Panel Testing
How a single assay reads dozens of cancer-risk genes at once, what the major panel tiers include, and why broader is not always clearer.
How panels workBRCA & Hereditary Variants
BRCA1, BRCA2, and the other high- and moderate-penetrance genes — what they normally do, and what happens to risk when they fail.
Understand the genesPatient Registries
Why longitudinal registries like PROMPT exist, how pooled multi-institutional data sharpens risk estimates, and what they answer that a single result cannot.
Why registries matterSample Collection & Processing
Saliva kits, buccal swabs, and blood draws explained — how each captures germline DNA and what happens between the sample and the sequencer.
From sample to labPrecision Medicine
What a germline result changes about screening intervals, risk-reducing options, and — increasingly — therapy choices for those already diagnosed.
Results to decisionsWhy pathogenic, benign, and uncertain all appear on the same report
A panel does not return a simple yes or no. Each gene tested yields a classification: a variant may be pathogenic or likely pathogenic (linked to elevated risk), benign or likely benign (a normal human difference), or a variant of uncertain significance — a change whose effect the evidence cannot yet resolve. Uncertain findings are common, especially on broad panels and in populations historically underrepresented in genetic databases, and they are not a reason to act prematurely.
This is also why the size of a panel matters. Testing more genes finds more pathogenic variants, but it also surfaces more uncertain results and more moderate-risk genes whose management guidance is still maturing. Interpreting that mix — against a person's own and their family's medical history — is the work of a genetic counselor, and it is the reason results are best read with one rather than alone.
Frequently asked questions
Does a pathogenic variant mean I will get cancer?
No. A pathogenic germline variant raises lifetime risk — sometimes substantially — but penetrance is rarely complete. It is a probability, modified by the specific gene, family history, age, and other factors. Many carriers never develop cancer, and the value of knowing is the chance to screen earlier and consider risk-reduction.
If sporadic cancer runs in my family, should I still test?
Family history is the strongest signal that prompts testing, but it is not the whole picture. Some carriers have little visible family history because relatives are few, were diagnosed elsewhere, or inherited the variant through the father's line. A genetic counselor weighs personal and family history together to decide whether testing is informative.
What sample does germline testing actually use?
Germline DNA is present in nearly every nucleated cell, so saliva, a buccal (cheek) swab, or a blood draw all work. The choice is practical, not diagnostic — the underlying sequence is the same. Our sample-collection guide explains how each method captures and stabilizes that DNA.
Why do some results come back 'uncertain'?
A variant of uncertain significance is a real change whose effect the current evidence cannot classify as either harmful or harmless. As databases grow and registries accumulate longitudinal data, many of these are eventually reclassified. Most laboratories do not recommend medical action based on an uncertain result alone.
Is this site a place to order a test or buy a kit?
No. This is an independent educational reference on hereditary cancer genetics. We explain how testing, variants, registries, and precision medicine work. Decisions about whether to test belong with a qualified clinician or genetic counselor.
Understanding hereditary cancer genetics, from the sample to the sequence
Have a question about how panel testing, hereditary variants, or registries fit together? We are an educational reference — reach out and we'll point you toward the right explainer.